Product Images Emtricitabine And Tenofovir Disoproxil Fumarate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Emtricitabine And Tenofovir Disoproxil Fumarate NDC 65862-354 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg/300 mg (30 Tablet Bottle) - emtriteno fig1
This is a description of a medication called Emuricitabine and Tenofovir Disoproxil Fumarate tablets manufactured by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 200 mg of Emuricitabine and 300 mg of Tenofovir Disoproxil Fumarate equivalent to 245 mg of tenofovir disoproxil. The usual dosage and administration is mentioned in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) and the tablets are permitted to have excursions of 15° to 30°C (59° to 86°F). A pharmacist should dispense the medication and keep the container tightly closed in its original container. The text also provides the NDC number, batch code, and company's address.*
Chemical Structure-1 - emtriteno str1
Chemical Structure-2 - emtriteno str2
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.